These modulators of contractility displayed a mixed success, with mavacamten restoring the hyper-contractile phenotype of ACTC1-mutant hiPSC-CMs, but OM lacking functional recovery of hypo-contractility shown by MYH7-mutant cardiomyocytes. This evidence concerns the gene ACTC1 and ocular melanoma.